A new approach to restore lung function and reduce antibiotic resistance Read More

Disrupting bacterial biofilms and mucus to alter the progression of pulmonary diseases

View our Pipeline

Developing a new class of
glycopolymer-based therapeutics
that target key drivers
of pulmonary decline Read More


January 17, 2018

Synspira’s Novel Glycopolymer Proves Effective Against Antibiotic Resistance

 —Published study suggests that lead candidate SNSP113 may mitigate MRSA infections– 

Synedgen Microbiologist Vidya Narayanaswamy led publication

Read More

A breath of fresh air in the treatment of lung disease.